Trial Profile
The post-marketing clinical randomized study of eldecalcitol on fall-related physical performance in Japanese osteoporotic patients with frailty
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary) ; Alendronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms EFFECT
- Sponsors Chugai Pharmaceutical
- 01 Nov 2020 Results published in the Journal of Bone and Mineral Metabolism
- 16 Jun 2016 New trial record